Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Star Equity Holdings Inc (STRR)
NASDAQIndustrialsConglomeratesSnapshot 2026-11-04
$9.61-0.52%
Close 2026-11-04 · 1-day change
NASDAQIndustrialsConglomeratesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
1.13 → 1.13 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for STRR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Management shows confidence via insider stock purchases | A supporting condition in Star Equity Holdings Inc's published investment case. The stated target is Continued insider buying or no insider selling. | Intact | Significant insider selling or no insider buying for 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, acquisition-oriented industrials business rather than a proven durable compounder. The thesis is on watch: the signal has shifted from cautious to mixed, but recent performance remains weak and management execution is volatile.
The valuation evidence points to STRR as cheap versus peers, while the model’s confidence is low and its expectations gap is negative. The priced-in tag is justified, with low fragility, but that does not remove the business risks or establish that the low valuation reflects a clear opportunity.
Near term, earnings risk is elevated, with a record of consecutive misses and an August 2026 miss. Revenue rose from $31.9 million in 2025-Q1 to $50.1 million in 2026-Q1, but operating income worsened from a $1.724 million loss to a $4.015 million loss, so profitable growth is not yet evident. The October acquisition announcement adds a growth avenue, while the equity-securities event and limited evidence of cost improvement remain risks.
Over the multi-year view, the key question is whether organic growth, acquisitions, and operational improvements can turn revenue expansion into better operating results. Near term, industrials bellwether earnings and guidance could support or weaken sector momentum, while further weakening in jobs data could increase pressure on cyclical companies.
STRR has revenue growth and a recent acquisition announcement, but losses, repeated earnings misses, and uncertain execution leave the 1-to-3-year thesis fragile. The evidence supports a watchful, mixed view rather than a confirmed recovery. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company is working to improve earnings despite recent losses. |
| Improving |
| Net income remains negative through FY27 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain $0.25 per share preferred stock dividend | The company aims to keep paying $0.25 dividends on preferred stock. | Intact | Dividend on preferred stock is cut or suspended | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows about 21% next year | Analysts expect revenue to grow about 21% next year. | Broken | YoY revenue growth falls below 15% next year | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$1.01 → $1.13 · observed estimates
$0.25B → $0.25B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-25 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-26 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-27 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-28 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-29 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-30 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-07-31 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-01 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-02 | $1.23 | $253,192,330 | 2 / 3 |
| 2026-08-03 | $1.23 | $253,192,330 | 2 / 3 |
| 2026-08-04 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-05 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-06 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-08 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-09 | $1.23 | $253,192,330 | 2 / 3 |
| 2026-08-10 | $1.23 | $253,192,330 | 2 / 3 |
| 2026-08-12 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-13 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-14 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-15 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-16 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-17 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-18 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-19 | $1.01 | $253,192,333 | 2 / 3 |
| 2026-08-20 | $1.01 | $253,200,000 | 2 / 3 |
| 2026-08-21 | $1.01 | $254,766,667 | 2 / 3 |
| 2026-08-22 | $1.01 | $254,766,667 | 2 / 3 |
| 2026-08-23 | $1.01 | $254,766,667 | 2 / 3 |
| 2026-08-24 | $1.01 | $254,766,667 | 2 / 3 |
| 2026-08-25 | $1.01 | $254,766,667 | 2 / 3 |
| 2026-08-26 | $0.94 | $249,400,000 | 2 / 3 |
| 2026-08-27 | $0.94 | $249,400,000 | 2 / 3 |
| 2026-08-28 | $0.94 | $249,400,000 | 2 / 3 |
| 2026-08-29 | $0.94 | $249,400,000 | 2 / 3 |
| 2026-08-30 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-08-31 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-01 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-02 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-03 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-04 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-05 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-06 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-07 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-08 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-09 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-10 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-11 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-12 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-13 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-14 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-15 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-16 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-17 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-18 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-19 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-20 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-21 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-22 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-23 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-24 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-25 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-26 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-27 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-28 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-29 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-09-30 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-01 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-02 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-03 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-04 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-05 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-06 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-07 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-08 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-09 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-10 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-11 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-12 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-13 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-14 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-15 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-16 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-17 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-18 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-19 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-20 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-21 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-22 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-23 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-24 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-25 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-26 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-27 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-28 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-29 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-30 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-10-31 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-11-01 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-11-02 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-11-03 | $1.13 | $249,400,000 | 2 / 3 |
| 2026-11-04 | $1.13 | $249,400,000 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.